PROactive cohort study

Patient Reported Outcomes in children and Adolescents with Chronic/life-threatening diseases and Tailored InterVentions in a digital Environment (PROactive) cohort study...

Description

Children with a chronic disease face more obstacles than their healthy peers, which may impact their physical, social-emotional, and cognitive development. In the long run, children with a chronic disease reach developmental milestones later than the...

General Design

Type
Cohort study
Cohort type
Clinical cohort, Population cohort
Data collection type
Retrospective, Prospective
Design
Longitudinal
Design description
PROactive is a questionnaire-based cohort study focussing on mental well-being, psychosocial well-being and participation, with a life-course perspective using a continuous longitudinal approach. It encompasses children, adolescents, and young adults with chronic conditions across a wide age range and their parent(s). Depending on the timing of diagnosis, participants are included between the ages of 0 and 18.
Start/End data collection
2016 (ongoing)

Population

Countries
Netherlands (the)
Regions
Noord-Holland, Noord-Brabant, Utrecht
Number of participants
3000
Population age groups
Infant (0-23 months), Child (2-12 years), Adolescent (13-17 years), Young adult (18-24 years)

Organisations

Lead organisations
  • UMC Utrecht (UMCU)
    Netherlands (the)

    Researcher

Additional organisations
  • Haaglanden Medical Centre (HMC)
  • Jeroen Bosch Hospital (JBZ)

Contributors

Subpopulations

List of subpopulations for this resource...

No results for current selection

Collection events

List of collection events defined for this resource...

No results for current selection

Networks

Part of networks...

Publications

Access conditions

The first version of our Data Request & Publication Guidelines is available (dataverseNL). We have outlined the terms and conditions under which data reuse will be permitted. A data request requires researchers to complete an application detailing th...

Data access conditions
  • general research use
  • health or medical or biomedical research
  • disease specific research
Data use conditions
  • research specific restrictions
  • not for profit, non commercial use only
  • collaboration required
  • user specific restriction
  • project specific restriction
  • return to database or resource
  • clinical care use
Data access fee
false
Release type
Periodically
Release description
Monthly
Prelinked
false

Funding & Acknowledgements

Funding
• PROactive start received in 2015 WKZ onderzoeksfonds grant (nr: R3939; duration April 2016-April 2021 • PROactive Consequences of COVID-19 received in 2022 the Elisabeth v Freyborg grant (nr: N/A; duration July 2020- June 2022) • PROactive extension to non-academic hospitals received in 2022 a ZonMw program quality of care grant (nr: 05160482120001; duration May 2022 – December 2024) • PROactive-YA (adolescents) received in 2023 a Taskforce for Applied Research SIA, (Dutch: Regieorgaan SIA) grant no. RAAK.PRO05.057; duration April 2024 – April 2028.
Acknowledgements
This research is part of the PROactive cohort. All data originates from children under treatment at the Wilhelmina Children's Hospital Utrecht (WKZ). We are grateful to everyone who participated in this research or worked on this project to make it possible. [Name relevant disease group representatives]

Documentation